Galephar Pharmaceutical Research Inc.
Humacao, Humacao
- UEI
- T1WTEN8UEF47
- CAGE
- 9M9X9
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 552W+64J, Cll Jazmin, Humacao, 00791, Puerto Rico
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
SBA capabilities narrative
Pharmaceutical R&D and Manufacturing - Galephar is a specialty pharmaceutical research company that focuses on drug product development with its captive drug delivery system technology platforms. Our entity focuses on integrated solutions of new route of administration, improved bioavailability, and controlled release, pain management, and preventative care, designed to enhance the performance of medication. As a Minority Owned Small Business, with about 40 active genuine R&D programs at different stages. DEA for Schedule II and IV controlled substances approved. FDA approved sites for Manufacturing, Analytical testing and Packaging in Puerto Rico. cGMP, GLP and GDP full compliance. Production of R&D & clinical supply. Our pilot Plant and Analytical laboratory offers advanced equipment, instruments, and consumables to support research and analysis.
Our technology focuses on developing robust, secure and stable technology solutions to prevent misuse of medication.
Quick answers
Is Galephar Pharmaceutical Research Inc. registered in SAM.gov?
Yes. Galephar Pharmaceutical Research Inc.'s SAM.gov registration is active through September 2, 2027.
On GovTribe
See Galephar Pharmaceutical Research Inc.'s full federal record
- Similar vendors